Integrin β1, osmosensing, and chemoresistance in mouse ehrlich carcinoma cells

Research output: Contribution to journalArticle

Standard

Integrin β1, osmosensing, and chemoresistance in mouse ehrlich carcinoma cells. / Sørensen, Belinda Halling; Rasmussen, Line Jee Hartmann; Broberg, Bjørn Sindballe; Klausen, Thomas Kjær; Sauter, Daniel Peter Rafael; Lambert, Ian Henry; Aspberg, Anders; Hoffmann, Else Kay.

In: Cellular Physiology and Biochemistry, Vol. 36, No. 1, 26.05.2015, p. 111-132.

Research output: Contribution to journalArticle

Harvard

Sørensen, BH, Rasmussen, LJH, Broberg, BS, Klausen, TK, Sauter, DPR, Lambert, IH, Aspberg, A & Hoffmann, EK 2015, 'Integrin β1, osmosensing, and chemoresistance in mouse ehrlich carcinoma cells', Cellular Physiology and Biochemistry, vol. 36, no. 1, pp. 111-132. https://doi.org/10.1159/000374057

APA

Sørensen, B. H., Rasmussen, L. J. H., Broberg, B. S., Klausen, T. K., Sauter, D. P. R., Lambert, I. H., ... Hoffmann, E. K. (2015). Integrin β1, osmosensing, and chemoresistance in mouse ehrlich carcinoma cells. Cellular Physiology and Biochemistry, 36(1), 111-132. https://doi.org/10.1159/000374057

CBE

Sørensen BH, Rasmussen LJH, Broberg BS, Klausen TK, Sauter DPR, Lambert IH, Aspberg A, Hoffmann EK. 2015. Integrin β1, osmosensing, and chemoresistance in mouse ehrlich carcinoma cells. Cellular Physiology and Biochemistry. 36(1):111-132. https://doi.org/10.1159/000374057

MLA

Vancouver

Sørensen BH, Rasmussen LJH, Broberg BS, Klausen TK, Sauter DPR, Lambert IH et al. Integrin β1, osmosensing, and chemoresistance in mouse ehrlich carcinoma cells. Cellular Physiology and Biochemistry. 2015 May 26;36(1):111-132. https://doi.org/10.1159/000374057

Author

Sørensen, Belinda Halling ; Rasmussen, Line Jee Hartmann ; Broberg, Bjørn Sindballe ; Klausen, Thomas Kjær ; Sauter, Daniel Peter Rafael ; Lambert, Ian Henry ; Aspberg, Anders ; Hoffmann, Else Kay. / Integrin β1, osmosensing, and chemoresistance in mouse ehrlich carcinoma cells. In: Cellular Physiology and Biochemistry. 2015 ; Vol. 36, No. 1. pp. 111-132.

RIS

TY - JOUR

T1 - Integrin β1, osmosensing, and chemoresistance in mouse ehrlich carcinoma cells

AU - Sørensen, Belinda Halling

AU - Rasmussen, Line Jee Hartmann

AU - Broberg, Bjørn Sindballe

AU - Klausen, Thomas Kjær

AU - Sauter, Daniel Peter Rafael

AU - Lambert, Ian Henry

AU - Aspberg, Anders

AU - Hoffmann, Else Kay

PY - 2015/5/26

Y1 - 2015/5/26

N2 - Background/Aims: Altered expression of the integrin family of cell adhesion receptors has been associated with initiation, progression, and metastasis of solid tumors as well as in the development of chemoresistance. Here, we investigated the role of integrins, in particular integrin β1, in cell volume regulation and drug-induced apoptosis in adherent and non-adherent Ehrlich ascites cell lines. Methods: Adhesion phenotypes were verified by colorimetric cell-adhesion-assay. Quantitative real-time PCR and western blot were used to compare expression levels of integrin subunits. Small interfering RNA was used to silence integrin β1 expression. Regulatory volume decrease (RVD) after cell swelling was studied with calcein-fluorescence-self-quenching and Coulter counter analysis. Taurine efflux was estimated with tracer technique. Caspase assay was used to determine apoptosis. Results: We show that adherent cells have stronger fibronectin binding and a significantly increased expression of integrin α5, αv, and β1 at mRNA and protein level, compared to non-adherent cells. Knockdown of integrin β1 reduced RVD of the adherent but not of the non-adherent cells. Efflux of taurine was unaffected. In contrast to non-adherent, adherent cells exhibited chemoresistance to chemotherapeutic drugs (cisplatin and gemcitabine). However, knockdown of integrin β1 promoted cisplatin-induced caspase activity in adherent cells. Conclusion: Our data identifies integrin β1 as a part of the osmosensing machinery and regulator of cisplatin resistance in adherent Ehrlich cells.

AB - Background/Aims: Altered expression of the integrin family of cell adhesion receptors has been associated with initiation, progression, and metastasis of solid tumors as well as in the development of chemoresistance. Here, we investigated the role of integrins, in particular integrin β1, in cell volume regulation and drug-induced apoptosis in adherent and non-adherent Ehrlich ascites cell lines. Methods: Adhesion phenotypes were verified by colorimetric cell-adhesion-assay. Quantitative real-time PCR and western blot were used to compare expression levels of integrin subunits. Small interfering RNA was used to silence integrin β1 expression. Regulatory volume decrease (RVD) after cell swelling was studied with calcein-fluorescence-self-quenching and Coulter counter analysis. Taurine efflux was estimated with tracer technique. Caspase assay was used to determine apoptosis. Results: We show that adherent cells have stronger fibronectin binding and a significantly increased expression of integrin α5, αv, and β1 at mRNA and protein level, compared to non-adherent cells. Knockdown of integrin β1 reduced RVD of the adherent but not of the non-adherent cells. Efflux of taurine was unaffected. In contrast to non-adherent, adherent cells exhibited chemoresistance to chemotherapeutic drugs (cisplatin and gemcitabine). However, knockdown of integrin β1 promoted cisplatin-induced caspase activity in adherent cells. Conclusion: Our data identifies integrin β1 as a part of the osmosensing machinery and regulator of cisplatin resistance in adherent Ehrlich cells.

KW - Cisplatin

KW - Ehrlich Ascites Tumor Cells

KW - Gemcitabine

KW - Hypotonic cell swelling

KW - Integrin

KW - Multi-drug-resistance

UR - http://www.scopus.com/inward/record.url?scp=84928752956&partnerID=8YFLogxK

U2 - 10.1159/000374057

DO - 10.1159/000374057

M3 - Article

VL - 36

SP - 111

EP - 132

JO - Cellular Physiology and Biochemistry

JF - Cellular Physiology and Biochemistry

SN - 1015-8987

IS - 1

ER -